The information provided herein is generated by experimental artificial intelligence and is for informational purposes only.
Israeli startup PhaseV enhances clinical trial success with AI technology
Israeli AI startup PhaseV, co-founded in 2023 by Dr. Raviv Pryluk and Elad Berkman, is revolutionizing clinical trials for pharmaceutical and biotech companies. With 23 employees and $15 million raised, their AI platform aims to improve decision-making and enhance trial success rates, addressing the industry's 90% failure rate. Recently recognized as one of the Top 10 Israeli startups to watch in 2025, PhaseV is committed to making clinical trials more efficient and beneficial for patients.
Seems like the connection with the server has been lost. It can be due to poor or broken network. Please hang on while we're trying to reconnect...
Oh snap! Failed to reconnect with the server. This is typically caused by a longer network outage, or if the server has been taken down. You can try to reconnect, but if that does not work, you need to reload the page.
Oh man! The server rejected the attempt to reconnect. The only option now is to reload the page, but be prepared that it won't work, since this is typically caused by a failure on the server.